Dr. Christian Trendelenburg

Dr. Christian Trendelenburg, Novartis - Qepler Summits And Conferences

Dr. Christian Trendelenburg

Associate Director
Novartis
Basel, Switzerland
Novartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide.

Christian-Friedrich Trendelenburg is a senior toxicologist in Preclinical Safety (PCS) at the Novartis Institutes for Biomedical Research (NIBR) in Basel/Switzerland.

He is a scientific expert for the safety evaluation of impurities, extractables/leachables and excipients, with major focus on the safety evaluation of pharmaceutical products for children.

As Preclinical Safety project leader in the Neuroscience and Global Health therapeutic areas he represents PCS in global pro-ject teams to support drug development by summarizing, evaluating, and interpreting nonclinical safety aspects.

He graduated in biochemistry from the University of Kaiserslautern/Germany and has a PhD (Dr. rer. nat.) in Toxicology.

Christian has a strong background in all areas of safety sciences including agrochemical, food, chemical (home & personal care) and pharmaceutical products.

He is a EUROTOX-certified toxicologist and member of the German and Swiss toxicological societies (DGPT & SST).

Related Sessions:

Qepler - Extractables & Leachables Summit thumbnail Details

Extractables & Leachables
Summit 2019

Get the latest updates in regulation, analytical testing, risk & safety assessment, biocompatibility.
  • 15 Oct 2019
  • Berlin, DE
  • Pharma
Day 1: Tuesday, 15 October 2019
CASE STUDY: Safety assessment of extractables/leachables: Challenges with different administration routes.
  • Safety thresholds for extractables/leachables in pharmaceutical products will be introduced
  • Applicability of these thresholds to products for different administration routes will be discussed
  • Specific safety considerations and approaches for parenteral and ophthalmic products are summarized
View Details
Qepler - 2nd Annual Extractables & Leachables Summit thumbnail Details

2nd Annual Extractables &
Leachables Summit 2020

Get the latest updates in regulation, analytical testing, risk & safety assessment, biocompatibility.
  • 22 Oct 2020
  • Virtual,
  • Pharma
Day 2: Friday, 23 October 2020
CASE STUDY: Safety assessment of extractables/leachables: Challenges with ophthalmic administration routes
  • General safety considerations for the safety assessment of extractables/leachables (E&L) in pharmaceutical products will be summarized
  • Current safety thresholds applicable to E&L in pharmaceutical products will be introduced
  • Specific safety considerations and approaches for E&L in ophthalmic products will be discussed
View Details
This website stores cookies on your computer. These cookies are used to collect information about how you interact with our website and allow us to remember you. We use this information in order to improve and customize your browsing experience and for analytics and metrics about our visitors both on this website and other media. To find out more about the cookies we use, see our Cookies Policy.